Global Contract Research Organization (CROs) Services Market is valued at USD 51.09 Billion in 2020 and expected to reach USD 98.42 Billion by 2027 with the CAGR of 9.82% over the forecast period
Rising demand for research and developments related to the new drug discovery with increased outsourcing activities and surge in clinical trials for fighting against various infectious diseases are some important factor driving the growth of contract research organizations (CRO) market.
Contract Research Organizations are the organization which offers services to the various industries like healthcare, chemical, biopharmaceutical, and pharmaceutical companies etc. in the form of outsourced research. Contract research organizations are useful to the wide range of the small, medium as well as large international companies and organizations for better product or service development in the niche domain groups including various sectors. Many factors are taken into consideration before selecting a contract research organization service such as scientific expertise, technology capability, geographical presence, access to data and cost efficiency. There are many benefits of taking contract research organization assistance such as time efficiency, expertise and experience, cost effectiveness and proper research. However, there are some disadvantages like confidentiality and communication management. Contract research organizations also provides drug development services, regulatory & scientific support, infrastructure & staffing support to deliver their clients with the flexibility to raise domestic capabilities or to deliver a fully outsourced solution.
The global contract research organization (CRO) services market is segmented on the basis of type, therapeutic area, service type, end user and geography. On the basis of type, global contract research organization (CRO) services market is divided into preclinical, clinical research and laboratory. On the basis of therapeutic area global contract research organization (CRO) services market is divided into oncology, central nervous system disorders, infectious diseases and cardiovascular diseases. On the basis of service type it is divided into clinical trial services, medical writing services, regulatory services, clinical data management services and others. On the basis of end user global contract research organization (CRO) services market is divided into pharmaceutical and biopharmaceutical, medical device companies, academic and research institutes and non-governmental organizations. According to the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) in 2020, registered research-based pharmaceutical industries have been employed more than 2 million people for research, development and provide medicines and vaccines that improve the life of patients worldwide. In addition to this, the number of new biological or chemical research based products launched globally in the market has been increased to 226 in the 2011-2015 period compared with 146 in the earlier decade.
Contract research organizations Services are also known as clinical research organization and these companies provide support to the lifescience industry by providing them research services on contract basis. These organizations are designed to reduce the manufacturing cost of novel drug and also provide easy access to the market. These organizations also offer clinical trials to the pharmaceutical or medical devices companies which also help them to get FDA or EMA approval for the product without any extra expenses. These approvals are required by the company to assure the safety and efficacy of the product.
Contract Research Organization (CROs) Services Market report is segmented on service type, Therapeutic area, end user and by regional & country level. Based upon service type, Contract Research Organization market is segmented into Early Phase Development Services, clinical research services, Laboratory and consulting services. On the basis of therapeutic area, market is segmented into oncology, clinical pharmacology, cardiology, infectious disease, Neurology, Ophthalmology, gastroenterology and hepatology, and others. Based upon end use, Contract Research Organization market is classified into Pharmaceutical & biopharmaceutical companies, Medical device companies, and Academic institutes.
The regions covered in global contract research organization (CRO) services Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, Global Melanoma Drug Market sub divided in to U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Global Contract Research Organization (CRO) Services Market reports cover prominent players like Laboratory Corporation of America Holdings, IQVIA, PAREXEL International Corporation, Pharmaceutical Product Development LLC,PRA Health Sciences Inc., ICON plc., InVentiv Health Inc., Charles River Laboratories International Inc., INC Research Holdings Inc. (U.S.), Wuxi PharmaTech Inc., LabCorp, Syneos Health, MPI Research,SGS, Covance Inc., Ricerca Biosciences, SynteractHCR, MeDPAce Holdings, Chiltern, CMIC, Galapagos NV, LAB Research Inc., Omnicare Clinical Research Inc., United BioSource Corporation, BioClinica, Aptuit, PharmaNet Development Group Inc., Galapagos NV, LAB Research Inc. and ReSearch Pharmaceutical Services.
Global Contract Research Organization (CRO) Services Market Dynamics –
The key factor for growth of global contract research organization (CRO) services market is the rise of demand in the market by Pharmaceutical and Biotechnological companies for outsourcing of research and development activities including various clinical trials for advanced new drugs against various infectious diseases like Swine flu,Covid-19 virus etc. According to WHO in 2020, there has been significant death troll happened worldwide due to this infectious disease corona virus till now around 10000 deaths has been noted with more than 209839 infected cases around 169 countries. The contract based research on finding the vaccination for treatment of corona virus has been started by various organizations in different countries. As per National Institute of Allergy and Infectious Diseases, the first testing in humans of an experimental vaccine for the new corona virus has been started on 16th of March 2020. But, global contract research organization (CRO) services market is hampered by some of the major factors including the high cost of labor, structural changes in organization & employment, conversation rate instability and fight of contract research to developing countries. Moreover, rising focus on specialty medicines with technological advancement using artificial intelligence, IoT, big data for the clinical research will create huge opportunity for this market and is expected to fuel the global contract research organization (CRO) services market during the forecast period.
Increase in the novel drug development by the pharmaceutical companies and increase in research and development activities over the period of time are expected drive the growth of Contract research organization
Some of the major factors drives the growth of contract research organization market over the period of time include the novel drug development by the pharmaceutical companies. The constant increase in the chronic disorders is expected to raise the demand for advanced drug for the treatment and for this pharmaceutical companies are constantly striving for the same. Furthermore, increase in research and development activities are expected to fuel the growth of contract research organization market over the near future. Moreover, increase investment by the government to further promote the research and development activities for the drug development are expected to create ample opportunities in the market. However, High cost and intellectual property rights are expected to hamper the growth of contract research organization market over the forecast period.
Contract Research Organizations (CRO) Market Regional Analysis –
North America is expected to dominate the contract research organizations (CRO) market with the potential rate due to presence of biopharmaceutical, and pharmaceutical companies for clinical research studies. According to the Pharmaceutical Research and Manufacturers Association (PhRMA), U.S. firms has more than half of the world's research & development in pharmaceuticals spending USD 75 billion and hold the intellectual property rights on most new medicines through its advanced contract based clinical research. The U.S. has the substantial overall economic impact of the biopharmaceutical industry which accounted for more than USD 1.3 trillion in economic output, representing 4 percent of total U.S. output in 2015 alone.
And Also North America accounted for largest share to dominate the contract research organization market. The U.S. holds the major market share which was closely followed by Canada and others countries. Due to the various guidelines with regards to clinical trials and most of the major Pharmaceutical companies belongs to the region. Europe is expected to be the second largest growing economy after North America. The presence of advanced infrastructure and increase in research and development activities are expected to create ample opportunities for the contract research organization market. Asia Pacific is expected to be the fastest growing region over the period of time due to the presence of developing economies such as India, China and others. There is an increase in the presence of pharmaceutical companies in the region coupled with increase in the demand for novel drugs for the treatment of chronic disorders are expected to promote the growth of contract research organization market. Latin America, Middle East and Africa is expected to develop moderately over the forecast period.
Europe is the second-largest region for dominating the growth of Contract Research Organizations (CRO) equipment due to rise of NCDs (Non-communicable Diseases) like diabetes, cardiovascular diseases, cancer, and chronic diseases. According to WHO, the Europe region accounts to rise of NCDs with around 77% of the disease burden which directly increases the demand for contract research organizations (CRO)s to prevent prevalence of these diseases.
The Asia Pacific is expected to emerge as the fastest-growing regional market due to rapidly increasing the prevalence of therapeutic and chronic diseases like diabetes, infectious diseases and cardiovascular diseases.
Key Benefits for Contract Research Organizations (CRO) Market Reports –
Global Contract Research Organizations (CRO) Market report covers in depth historical and forecast analysis.
Global Contract Research Organizations (CRO) Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
Global Contract Research Organizations (CRO) Market report helps to identify opportunities in market place.
Global Contract Research Organizations (CRO) Market report covers extensive analysis of emerging trends and competitive landscape.
By Therapeutic area:
By Service Type:
By End-user Type:
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us firstname.lastname@example.orgJOIN US
BrandEssence® Market Research and Consulting Pvt ltd.
124, City Road, London EC1V 2NX
© Copyright 2023-24 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®